Oklo Inc. received startup authorization from the U.S. Department of Energy (DOE) for its Groves Isotope Test Reactor in Texas. This final regulatory milestone allows the company to load nuclear fuel and commence operations. The authorization was granted 10 months after the project's groundbreaking.
The Groves facility is a low-power test reactor designed to demonstrate Oklo's design, construction, and operational systems. It serves as a precursor to commercial-scale domestic production of critical isotopes.
These isotopes have essential applications in cancer treatments, scientific research, and national security.